These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1065 related items for PubMed ID: 18590428

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Clinical characteristics of patients with thyrotropin-secreting pituitary adenoma.
    Wu YY, Chang HY, Lin JD, Chen KW, Huang YY, Jung SM.
    J Formos Med Assoc; 2003 Mar; 102(3):164-71. PubMed ID: 12783133
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Thyrotropin-secreting pituitary tumor and Hashimoto's disease: a novel association.
    Iskandar SB, Supit E, Jordan RM, Peiris AN.
    South Med J; 2003 Sep; 96(9):933-6. PubMed ID: 14513996
    [Abstract] [Full Text] [Related]

  • 9. Endoscopic endonasal transsphenoidal surgery for growth hormone-secreting pituitary adenomas.
    Hofstetter CP, Mannaa RH, Mubita L, Anand VK, Kennedy JW, Dehdashti AR, Schwartz TH.
    Neurosurg Focus; 2010 Oct; 29(4):E6. PubMed ID: 20887131
    [Abstract] [Full Text] [Related]

  • 10. Macro- and microadenoma of thyrotropin secreting pituitary tumors--two clinical cases.
    Hubalewska-Hola A, Fröss K, Kostecka-Matyja M, Sowa-Staszczak A, Szybiński Z, Huszno B, Ptak M.
    Przegl Lek; 2003 Oct; 60(11):768-71. PubMed ID: 15058054
    [Abstract] [Full Text] [Related]

  • 11. Surgical treatment of thyrotropin-secreting pituitary adenomas.
    McCutcheon IE, Weintraub BD, Oldfield EH.
    J Neurosurg; 1990 Nov; 73(5):674-83. PubMed ID: 2213157
    [Abstract] [Full Text] [Related]

  • 12. Active and silent thyroid-stimulating hormone-expressing pituitary adenomas: presenting symptoms, treatment, outcomes, and recurrence.
    Kirkman MA, Jaunmuktane Z, Brandner S, Khan AA, Powell M, Baldeweg SE.
    World Neurosurg; 2014 Dec; 82(6):1224-31. PubMed ID: 24657816
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. A thyrotropin-secreting macroadenoma with positive growth hormone and prolactin immunostaining: A case report and literature review.
    Kuzu F, Bayraktaroğlu T, Zor F, G N BD, Salihoğlu YS, Kalaycı M.
    Niger J Clin Pract; 2015 Dec; 18(5):693-7. PubMed ID: 26096253
    [Abstract] [Full Text] [Related]

  • 15. Diagnosis and treatment of TSH-secreting adenomas: review of a longtime experience in a reference center.
    Nazato DM, Abucham J.
    J Endocrinol Invest; 2018 Apr; 41(4):447-454. PubMed ID: 29022276
    [Abstract] [Full Text] [Related]

  • 16. Endoscopic endonasal transsphenoidal surgery in elderly patients with pituitary adenomas.
    Gondim JA, Almeida JP, de Albuquerque LA, Gomes E, Schops M, Mota JI.
    J Neurosurg; 2015 Jul; 123(1):31-8. PubMed ID: 25839926
    [Abstract] [Full Text] [Related]

  • 17. Pituitary adenomas in childhood and adolescence. Results of transsphenoidal surgery.
    Partington MD, Davis DH, Laws ER, Scheithauer BW.
    J Neurosurg; 1994 Feb; 80(2):209-16. PubMed ID: 8283258
    [Abstract] [Full Text] [Related]

  • 18. Primary Medical Treatment of Thyrotropin-Secreting Pituitary Adenomas by First-Generation Somatostatin Analogs: A Case Study of Seven Patients.
    Rimareix F, Grunenwald S, Vezzosi D, Rivière LD, Bennet A, Caron P.
    Thyroid; 2015 Aug; 25(8):877-82. PubMed ID: 26244412
    [Abstract] [Full Text] [Related]

  • 19. Endoscopic endonasal transsphenoidal surgery for functional pituitary adenomas.
    Hofstetter CP, Shin BJ, Mubita L, Huang C, Anand VK, Boockvar JA, Schwartz TH.
    Neurosurg Focus; 2011 Apr; 30(4):E10. PubMed ID: 21456921
    [Abstract] [Full Text] [Related]

  • 20. Efficacy of the long-acting octreotide formulation (octreotide-LAR) in patients with thyrotropin-secreting pituitary adenomas.
    Caron P, Arlot S, Bauters C, Chanson P, Kuhn JM, Pugeat M, Marechaud R, Teutsch C, Vidal E, Sassano P.
    J Clin Endocrinol Metab; 2001 Jun; 86(6):2849-53. PubMed ID: 11397898
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 54.